HØREKLINIKKEN VALBY ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
Estimate generation in progress, please wait...
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  8.0% 25.9% 10.9% 12.7% 16.9%  
Credit score (0-100)  32 3 21 18 7  
Credit rating  BB B BB BB BB  
Credit limit (kDKK)  0.0 -0.0 -0.0 -0.0 -0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  53.6 31.7 22.1 33.9 38.5  
EBITDA  53.6 -804 21.4 33.9 38.5  
EBIT  53.6 -804 21.4 33.9 38.5  
Pre-tax profit (PTP)  57.0 -826.3 21.6 23.6 23.7  
Net earnings  57.0 -826.3 21.6 23.6 23.7  
Pre-tax profit without non-rec. items  57.0 -826 21.6 23.6 23.7  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  277 -550 -528 -504 -481  
Interest-bearing liabilities  0.0 0.0 566 0.0 0.0  
Balance sheet total (assets)  866 44.5 44.0 7.3 7.1  

Net Debt  -0.8 -0.7 566 -1.4 -0.9  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  53.6 31.7 22.1 33.9 38.5  
Gross profit growth  110.0% -40.9% -30.4% 53.7% 13.6%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  866 44 44 7 7  
Balance sheet change%  30.1% -94.9% -1.1% -83.5% -2.6%  
Added value  53.6 -803.5 21.4 33.9 38.5  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  4.0 -1.0 1.0 2.0 3.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  100.0% -2,533.0% 97.1% 100.0% 100.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  12.6% -110.0% 3.7% 6.3% 7.8%  
ROI %  29.1% -580.9% 7.6% 12.1% 0.0%  
ROE %  23.0% -514.7% 49.0% 92.1% 331.4%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  31.9% -92.5% -92.3% -98.6% -98.6%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -1.6% 0.1% 2,641.5% -4.1% -2.3%  
Gearing %  0.0% 0.0% -107.2% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  47.3% 0.0% 0.0% 3.7% 0.0%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  1.5 0.1 0.1 0.0 0.0  
Current Ratio  1.5 0.1 0.1 0.0 0.0  
Cash and cash equivalent  0.8 0.7 0.0 1.4 0.9  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  276.6 -549.7 -528.0 -504.5 -480.7  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0